|
|
|
|
2 Department of Physiology and 3 Department of Biomedical Sciences, Midwestern University, Glendale, AZ 85308; 4 Department of Biomedical Sciences of the College of Veterinary Medicine, 5 Dalton Cardiovascular Research Center, 6 Veterinary Medical Diagnostic Laboratory of the College of Veterinary Medicine, 7 Department of Medical Pharmacology and Physiology of the College of Medicine, and 8 Center for Gender Physiology and Environmental Adaptation, University of Missouri, Columbia, MO
* To whom correspondence should be addressed. E-mail: lalnak{at}midwestern.edu.
| ABSTRACT |
|---|
|
|
|---|
3.56.9 µmol/L) than those fed 0 G (
100 nmol/L). Anion substitution experiments and bumetanide-sensitivity demonstrated that chloride was the major anion mediating the increased secretion. A smaller bicarbonate component was not augmented by consumption of the genistein diet. These data indicate that chronic exposure to dietary genistein stimulates a sex-dependent increase in basal and forskolin-stimulated chloride secretion across murine intestine.
| Introduction |
|---|
|
|
|---|
Additionally, in cell culture systems, we and others have shown that genistein stimulates the epithelial chloride channel, wild-type (Wt)9 cystic fibrosis transmembrane conductance regulator protein (CFTR) (10). More recent studies have shown that genistein increases the open probability of the most common cystic fibrosis (CF) disease-associated mutation,
F508-CFTR, to levels comparable to those seen in Wt-CFTR (11,12). These data suggest that genistein may have therapeutic potential for treating CF. Moreover, the effectiveness of genistein to improve
F508-CFTR in in vitro cell systems with a 50% effective concentration of 5 µmol/L (13,14) is within the physiological range attainable by dietary modifications. Genistein is readily absorbed across the intestines and can readily reach micromolar concentrations in serum (15). Intestinal whole-animal absorption of genistein was evaluated in rats (16), indicating that genistein is highly bioavailable. Mice consuming 750 mg/L genistein generate plasma genistein concentrations of
2 µmol/L (17). These levels are comparable to a soy milk diet in humans that also results in plasma genistein concentrations of
2 µmol/L (18).
Acute bilateral application of genistein to Wt murine distal colon (19) increased short circuit current (Isc), which is indicative of increased anion secretion. Additionally, acute application of genistein increased current and conductance in depolarized colonic mucosa from normal and CF mice (20). The flavonol quercetin also increased chloride (and likely bicarbonate) secretion in rat small and large intestine (21).
To our knowledge, to date there are no studies assessing the effect of chronic dietary genistein on intestinal function in mice. Data presented here describe the effect of chronic (1 mo) dietary supplementation with genistein on small intestine epithelial anion secretion in mice. We hypothesized that chronic exposure to elevated levels of dietary genistein would generate an increase in transepithelial chloride secretion in intestinal epithelia via augmentation of CFTR channel activity.
| Materials and Methods |
|---|
|
|
|---|
Diets. Casein-based diets were prepared by Dr. R. S. MacDonald (Department of Nutrition, Iowa State University) and contained either 600 G or 0 G (Table 1). Importantly, diets contained equivalent amounts of protein (20.3 g), carbohydrate (66 g), and fat (5 g) and had an estimated energy content of 16.28 kJ/g. Diets were formulated as a powder and mice were allowed to eat ad libitum. Although food intake was not monitored, all mice in this study continued to gain weight.
|
3 and 11%, respectively.
Bioelectric measurement of intestinal secretion.
Via an abdominal incision,
5 cm of mid-jejunum was removed and placed in ice-cold oxygenated Krebs bicarbonate ringer (KBR). Each mouse yielded 34 jejunum pieces, isolated as previously described (19,2527). Jejunum sections mounted in the Ussing chambers had 0.238 cm2 exposed surface area. Transepithelial Isc (reported as µA/cm2) was measured via an automatic voltage clamp (VCC-600, Physiologic Instruments) and the experimental conditions and methods were previously described (28). Intestinal tissue pieces were constantly maintained in 1 µmol/L indomethacin (to minimize tissue exposure to endogenously generated prostanoids resulting from manipulation and mounting of the tissue) (29). Glucose (10 mmol/L) was added to the serosal KBR bath and mannitol (10 mmol/L) substituted for glucose in the mucosal KBR bath to avoid an inward current due to Na+-coupled glucose transport (28). Once mounted, the serosal side was exposed to tetrodotoxin (0.1 µmol/L) to minimize variations in intrinsic intestine neural tone (30). Intrinsic neural tone limits the absorptive capacity of the murine mucosa, and neural block is denoted by a decrease in Isc.
Experimental protocols. Tissues were exposed to KBR for 20 min and steady-state basal Isc measured at that time. cAMP-dependent anion secretion was assessed by bilateral application of 10µmol/L forskolin (at 20 min) and steady-state forskolin response was taken at 60 min. Addition of bumetanide (100 µmol/L, serosal), a Na+/K+/2Clcotransporter, indicates the chloride secretory component. At the end of each experiment, glucose (10 mmol/L, mucosal) was added to stimulate Na+-coupled glucose transport to assess tissue viability (denoted by >10% increase in Isc). Tissues that failed to respond to glucose within this parameter were discarded. On separate intestinal segments we determined the Na+-coupled glucose transport, as assessed by the phloridzin-sensitive Isc (phloridzin inhibits the Na+-glucose symporter) in the presence of mucosal glucose, with mannitol added to the serosal side to maintain osmolarity. Most experiments were performed in the presence of KBR (chloride/bicarbonate present). To determine the contribution of chloride secretion to the genistein-stimulated basal and forskolin-stimulated Isc, chloride-free KBR (bicarbonate present) was utilized. To test for the presence of a bicarbonate secretory component, tissues were bathed in chloride/bicarbonate-free KBR. KBR contained the following (mmol/L): 115 NaCl, 25 NaHCO3, 5 KCl, 1.2 MgCl2 and 1.2 CaCl2 mmol/L, pH 7.4. Chloride-free KBR contained the following: 0.4 KH2PO4, 2.4 K2HPO4, 115 NaGluconate, 25 NaHCO3, 2.4 hemicalcium, 1.2 MgSO4, and 3 CaSO4, pH 7.4. Chloride-bicarbonate-free KBR contained the following (mmol/L): 115 NaGluconate, 5 KGluconate, 25 NaTES, 3 CaSO4, 2.4 hemicalcium, and 1.2 MgSO4, pH 7.4.
Chemicals. Forskolin was purchased from Calbiochem and stored as 20 mmol/L stock in dimethyl sulfoxide (DMSO) at 20°C. All other chemicals were obtained from Sigma Chemical.
Statistics. Values are means ± SEM. Numbers in parentheses represent numbers of tissues used from individual mice. Analysis was computed using a mixed 2-way ANOVA to compare time (repeated measure) and diet (independent measure) or using a mixed 2-way ANOVA pairwise comparison with Bonferroni multiple comparison test.
| Results |
|---|
|
|
|---|
Serum genistein concentration was negligible in female (107.17 ± 19.42 nmol/L, n = 8) and male (104.97 ± 8.59 nmol/L, n = 5) mice fed the 0 G diet. In those fed the 600 G diet, the serum genistein concentration was greater (P < 0.05) in both females (7731.36 ± 3831.74 nmol/L, n = 6; range = 1110.18, 3580.84, 3054.66, 20958.57, 1538.16, 16145.89 nmol/L) and males (3974.77 ± 2141.54 nmol/L, n = 5; range = 6517.19, 737.09, 1231.28, 1057.66, 10330.59 nmol/L). The serum estradiol concentration did not differ between female mice fed the 600 G diet (33.41 ± 6.98 pmol/L, n = 5) and the 0 G diet (40.38 ± 5.14 pmol/L, n = 5).
Ussing chamber bioelectric measurements. Basal Isc increased in female mice fed 600 G for 4 wk compared with those fed 0 G (P = 0.0021, Fig. 1A). Interestingly, we found that jejuna removed from male mice fed 600 G for 4 wk did not exhibit an increased basal anion secretion (Fig. 1B) and basal Isc was comparable in jejuna removed from male mice fed either 600 G or 0 G. Furthermore, females fed 600 G had a higher basal Isc than males fed 600 G (P = 0.0023, Fig. 1C). Bilateral application of 10 µmol/L forskolin increased Isc in all mice and diet groups (female and male), which peaked and then remained elevated. However, the steady-state forskolin-stimulated Isc was greater in female mice fed 600 G than in those fed 0 G (P = 0.0007, Fig. 1A). In contrast, in male mice, the steady-state forskolin-stimulated Isc was unchanged by the 600 G diet, compared with the 0 G diet (Fig. 1B). Females fed the 600 G diet generated greater forskolin-stimulated Isc than males fed the same diet (P = 0.00084, Fig. 1C).
|
|
|
| Discussion |
|---|
|
|
|---|
40 µA/cm2) in female mice fed either 600 G or 0 G, which suggested that increased dietary genistein does not increase the bicarbonate-mediated anion secretion. In the normal murine intestine, chloride secretory responses to forskolin have long been detected, and the major route for the chloride exit across the apical membrane is via the CFTR chloride channel (3234). Nonetheless, other potential pathways exist for chloride to exit across the apical membrane of intestinal epithelia. Recently, apical chloride secretory pathways (ClC-2 and/or ClC-4) were identified (35,36); however, there is little information regarding the effects of genistein on these chloride channels. Based on the large body of evidence in the literature regarding genistein's action in vitro on CFTR (10,13,14), we predicted that at least one pathway mediating genistein's action in the jejuna epithelia would be on the CFTR chloride channel.
Flavonoids (such as genistein) are found naturally in soy and plants and are digested in an average daily diet. Soy-rich diets have been shown to generate micromolar serum genistein concentrations (37). In fact, 1 µmol/L serum genistein concentrations can be obtained in rats consuming a diet containing 750 µg genistein/g (38). More recently, Bhandari et al. (39) showed a relation between dietary genistein and serum levels in mice (1000 mg/kg dietary genistein generated
1.5 µmol/L serum genistein and 500 mg/kg dietary genistein generated
0.5 µmol/L serum genistein) after 4 wk of consuming the study diets. In comparison, our female and male mice fed 600 G had serum genistein levels of 7.73 ± 4.038 µmol/L and 4.18 ± 2.25 µmol/L, respectively. Thus, based on research evidence that µmol/L levels of genistein are required to stimulate CFTR channel activity, our data attests that regular continued consumption of genistein has a viable potential to maintain serum levels in a low (<5) µmol/L range. Large variations in serum genistein levels obtained from mice fed 600 G could be due to uncontrolled eating behaviors by the mice (the mice in this study were not fasted prior to experimentation). Furthermore, clearance rates of serum genistein may be different between females and males; in fact, evidence suggests that female mice have greater circulating concentrations than males after consuming identical genistein-rich diets (40,41).
Our observation, that intestinal epithelial anion secretion was increased only in female mice, and not males, following chronic dietary genistein exposure, was intriguing. Several potential mechanisms could account for the sex-dependent difference in genistein's action on intestinal secretion. First, it is presently unknown whether levels of CFTR expression in male and female murine intestinal epithelia are equivalent under normal dietary conditions (less CFTR expression in males vs. females could account for this difference in chloride secretion). It is also unclear whether dietary genistein alters trafficking of CFTR to the epithelial plasma membrane. Such regulation of CFTR trafficking in intact epithelial tissue has been shown in the Spiny Dogfish rectal gland (42) and, more recently, in a cell culture system (43). Future studies are required to examine levels of CFTR expression. Second, genistein is capable of binding to estrogen receptors ER
and ERß (44,45), both of which are found in the intestine (46,47). Thus, sex-dependent differences in intestinal epithelial function could be predicted if dietary genistein were to act via an ER-mediated pathway, and/or if there were differences in the ER types or numbers present in male and female murine intestine.
Interestingly, Singh et al. (48) reported that 17ß-estradiol caused a rapid and reversible inhibition of forskolin-stimulated chloride secretion across T84 epithelial cell monolayers (Ki = 9 µmol/L). The difference in response by 17ß-estradiol on forskolin-stimulated chloride secretion in T84 monolayers and our observations with genistein could be due to: 1) they used a concentration of forskolin (10 µmol/L) which generally elicits a maximal CFTR-mediated current (49) that can not be further potentiated, 2) it is possible that 17ß-estradiol [like genistein (50)] has a biphasic stimulatory and inhibitory effect, and 3) the cell systems used are different and therefore involve alternative pathways in either system. Additionally, genistein has been shown to upregulate expression of genes through the estrogen response element in an intestinal epithelial cell line (51). Whether dietary genistein modifies gene expression remains to be seen.
Third, in serum pharmacokinetic studies, male and female mice (C57BL6), given either identical subcutaneous administration of genistein (15 d) or fed genisteincontaining diets (28 d), generated differences in maximal concentrations of total genistein. Females had greater circulating levels than males (40,41). Thus, reduced circulating levels of genistein in males may account for the sex-dependent differences we observed. This may provide some of the mechanistic rationale for the reduced basal and forskolin-stimulated Isc response exhibited by males fed the genistein-rich diet. Lastly, there is evidence to suggest that estradiol activates cAMP-dependent protein kinase activity in rat colon (52). Because genistein is structurally similar to estradiol and binds to estrogen receptors, it is conceivable that genistein could potentially also activate the cAMP-dependent protein kinase pathway, which would thereby augment CFTR activity in the intestinal epithelia.
Although the mechanism(s) underlying the genistein-mediated increased anion secretion in the intestinal epithelium are currently unclear, this study provides, to our knowledge, the first evidence that increased consumption of dietary genistein, a naturally occurring isoflavone, increases both basal and cAMP-stimulated intestinal anion secretion in female mice.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
9 Abbreviations used: 600 G, 600 mg/kg genistein; 0 G, 0 mg/kg genistein; Isc, short circuit current; CFTR, cystic fibrosis transmembrane conductance regulatory protein; CF, cystic fibrosis; Wt, wild-type; KBR, Krebs bicarbonate ringer. ![]()
Manuscript received 28 February 2006. Initial review completed 28 March 2006. Revision accepted 22 August 2006.
| LITERATURE CITED |
|---|
|
|
|---|
1. Murphy PA. Phytoestrogen content of processed soybean products. Food Technol. 1982;36:604.
2. Nagai M, Hashimoto T, Yanagawa H, Yokoyama H, Minowa M. Relationship of diet to the incidence of esophageal and stomach cancer in Japan. Nutr Cancer. 1982;3:25768.[Medline]
3. Severson RK, Nomura AMY, Grove JS, Stemmermann GN. A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii. Cancer Res. 1989;49:185760.
4. Lee HP, Gourley L, Duffy SW, Esteve J, Lee J, Day NE. Dietary effects on breast cancer risk in Singapore. Lancet. 1991;337:1197200.[Medline]
5. Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol. 1997;146:294306.
6. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA. 1993;90:26904.
7. Kirk EA, Sutherland P, Wang SA, Chait A, LeBoeuf RC. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice. J Nutr. 1998;128:9549.
8. Wong W, Smith E, Stuff J, Hachey D, Heird W, Pownell H. Cholesterol-lowering effect of soy protein in normocholesterolemic and hypercholesterolemic men. Am J Clin Nutr. 1998;68:1385S9S.[Abstract]
9. Lichtenstein A. Soy protein, isoflavones and cardiovascular disease risk. J Nutr. 1998;128:158992.
10. Illek B, FIscher H, Santos GF, Widdicombe JH, Machen TE, Reenstra WW. cAMP-independent activation of CFTR Cl channels by the tyrosine kinase inhibitor genistein. Am J Physiol. 1995;268:C88693.[Medline]
11. Hwang T-C, Wang F, Zeltwanger S, Yang I, Reenstra W. Genistein potentiates wild-type and ÐF508-CFTR channel activity. Am J Physiol. 1997;273:C988998.[Medline]
12. Al-Nakkash L, Hwang T-C. Activation of CFTR by pharmacological modulators. Pediatr Pulmonol. Suppl. 1997;14:71352.[Medline]
13. Al-Nakkash L, Hu S, Li M, Hwang T-C. A common mechanism for cystic fibrosis transmembrane conductance regulator protein activation by genistein and benzimidazolone analogs. J Pharmacol Exp Ther. 2001;296:46472.
14. Wang F, Zeltwanger S, Yang I, Nairn A, Hwang T-C. Actions of genistein on CFTR channel gating. J Gen Physiol. 1998;111:47790.
15. Barnes S, Sfakianos J, Coward L, Kirk M. Soy isoflavonoids and cancer prevention. Underlying biochemical and pharmacological issues. Adv Exp Med Biol. 1996;401:87100.[Medline]
16. Sfakianos J, Coward L, Kirk M, Barnes S. Intestinal uptake and biliary excretion of the isoflavone genistein in rats. J Nutr. 1997;127:12608.
17. Hsieh CY, Santell R, Haslam S, Helferich W. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 1998;58:38338.
18. Xu X, Wang H, Murphy P, Cook L, Hendrich S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr. 1994;124:82532.
19. Goddard CA, Evans M, Colledge W. Genistein activates CFTR-mediated Cl- secretion in the murine trachea and colon. Am J Physiol Cell Physiol. 2000;279:C38392.
20. Cuthbert A. Assessment of CFTR chloride channel openers in intact normal and cystic fibrosis murine epithelia. Br. J. Pharmacol. 2001;132:65968.[Medline]
21. Cermak R, Follmer U, Wolffram S. Dietary flavonol quercetin induces chloride secretion in rat colon. Am J Physiol. 1998;275:G116672.[Medline]
22. Franke AA, Custer LJ, Wang W, Shi CY. HPLC analysis of isoflavonoids and other phenolic agents from human fluids. Proc Soc Exp Biol Med. 1998;217:26373.[Medline]
23. Vom Saal FS, Quadagno DM, Even MD, Keisler LW, Keisler DH, Khan S. Paradoxical effects of maternal stress on fetal steroids and postnatal reprooductive traits in female mice from different intrauterine positions. Biol Reprod. 1990;43:75161.[Abstract]
24. Montano MM, Welshons WV, Vom Saal FS. Free estradiol in serum and brain uptake of estradiol during fetal and neonatal sexual differentiation in female rats. Biol Reprod. 1995;53:1198207.[Abstract]
25. Clarke LL, Harline MC. Dual role of CFTR in cAMP-stimulated HCO3- secretion across murine duodenum. Am J Physiol. 1998;274:G71826.[Medline]
26. Grubb BR, Boucher RC. Enhanced colonic Na+ absorption in cystic fibrosis mice versus normal mice. Am J Physiol. 1997;272:G393400.[Medline]
27. Grubb BR. Ion transport across the jejunum in normal and cystic fibrosis mice. Am J Physiol. 1995;268:G50513.[Medline]
28. Clarke LL, Grubb BR, Gabriel SE, Smithies O, Coller BH, Boucher RC. Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science. 1992;257:11258.
29. Clarke LL, Harline MC. CFTR is required for cAMP inhibition of intestinal Na+ absorption in a cystic fibrosis mouse model. Am J Physiol. 1996;270:G25967.[Medline]
30. Sheldon RJ, Malarchik ME, Fox DA, Burks TF, Porreca F. Pharmacological characterization of neural mechanisms regulating mucosal ion transport in mouse jejunum. J Pharmacol Exp Ther. 1989;249:57282.
31. Dietz J, Field M. Ion transport in rabbit ileal mucosa. IV. Bicarbonate secretion. Am J Physiol. 1973;225:85861.
32. Grubb BR. Ion transport across the normal and CF neonatal murine intestine. Am J Physiol. 1999;277:G16774.[Medline]
33. Anderson MP, Welsh MJ. Calcium and cAMP activate different chloride channels in the apical membrane of normal and cystic fibrosis epithelia. Proc Natl Acad Sci USA. 1991;88:60037.
34. Clarke LL, Grubb BR, Yankaskas JR, Cotton CU, McKenzie A, Boucher RC. Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(/) mice. Proc Natl Acad Sci USA. 1994;91:47983.
35. Rozmahel R, Wilschanski M, Matin A, Plyte S, Oliver M, Auerbach W, Moore A, Forstner J, Durie P, et al. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor. Nat Genet. 1996;12:2807.[Medline]
36. Gyomorey K, Garami E, Galley K, Rommens JM, Bear CE. Non-CFTR chloride channels likely contribute to secretion in the murine small intestine. Pflugers Arch. 2001;443:S1036.[Medline]
37. Hendrich S, Lee KW, Xu X, Wang HJ, Murphy PA. Defining food components as new nutrients. J Nutr. 1994;124:1789S92S.
38. Santell RC, Chang YC, Nair MG, Helferich WG. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr. 1997;127:2639.
39. Bhandari A, Crawford SE, Huang L, Reenstra WW. Effects of oral genistein in mice. Pediatr Pathol Mol Med. 2003;22:13141.[Medline]
40. Doerge DR, Twaddle NC, Banks EP, Jefferson WN, Newbold RR. Pharmacokinetic analysis in serum of genistein administered subcutaneously to neonatal mice. Cancer Lett. 2002;184:217.[Medline]
41. Morris SM, Akerman GS, Warbritton AR, Patton RE, Doerge DR, Ding X, Chen JJ. Effect of dietary genistein on cell replication indices in C57BL6 mice. Cancer Lett. 2003;195:13945.[Medline]
42. Lehrich RW, Aller SG, Webster P, Marino CR, Forrest JN. Vasoactive intestinal peptide, forskolin and genistein increase apical CFTR trafficking in the rectal gland of the spiny dogfish, Sqalus acanthias. J Clin Invest. 1998;101:73745.[Medline]
43. Schmidt A, Hughes L, Althaus J, Lunn J, Li H, Cai Z, et al. Expression, maturation and function of CFTR are altered by genistein treatment. Pediatr Pulmonol. Suppl. 2003;25:92394.[Medline]
44. So FV, Guthrie N, Chambers AF, Carroll KK. Inhibtion of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett. 1997;112:12733.[Medline]
45. Zava DT, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer. 1997;27:3140.[Medline]
46. Campbell-Thompson ML. Estrogen receptor alpha and beta expression in upper gastrointestinal tract with regulation of trefoil factor family 2 mRNA levels in ovariectomized rats. Biochem Biophys Res Commun. 1997;240:47883.[Medline]
47. Campbell-Thompson M, Lynch IJ, Bhardwaj B. Expression of estrogen receptor (ER) subtypes and ER Beta isoforms in colon cancer. Cancer Res. 2001;61:63240.
48. Singh AK, Schultz BD, Katzenellenbogen JA, Price EM, Bridges RJ. Estrogen inhibition of cystic fibrosis transmembrane conductance regulator-mediated chloride secretion. J Pharmacol Exp Ther. 2000;295:195204.
49. Al-Nakkash L, Hwang T-C. Activation of wild-type and ÐF508-CFTR by phosphodiesterase inhibitors through cAMP-dependent and -independent mechanisms. Pflugers Arch. 1999;437:55361.[Medline]
50. Wang F, Zeltwanger S, Yang IC-H, Nairn AC, Hwang T-C. Actions of genistein on cystic fibrosis transmembrane conductance regulator channel gating: Evidence for two binding sites with opposite effects. J Gen Physiol. 1998;111:47790.
51. Hua P, Tsai WJ, Kuo SM. Estrogen response element-independent regulation of gene expression by genistein in intestinal cells. Biochim Biophys Acta. 2003;1627:6370.[Medline]
52. Doolan CM, Condliffe SB, Harvey BJ. Rapid non-genomic activation of cytosolic cyclic AMP-dependent protein kinase activity and [Ca2+]i by 17Beta-oestradiol in female rat distal colon. Br J Pharmacol. 2000;129:137586.[Medline]
53. Reeves PG. Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr. 1997;127:838S41S.[Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||